McGill Newsroom
Neuron cell death may be caused by overactive immune system
A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.
It’s all math: How Professor Alan Evans is using cutting-edge statistics to unravel the complexity of brain disorders.
When Alan Evans was starting out in the 1970s, researchers didn’t ask the boss to foot their bar tab. But that’s exactly what some of the coders in his Montreal Neurological Institute lab recently proposed: a 9-to-5 Saturday hackathon, held in an Irish pub a few blocks from the McGill University campus.
EMC working with McGill to support data storage and visualization technologies to help with the NeuroHub project
The Canadian research team that helped spearhead the international brain-mapping project known as BigBrain is about to get a major boost in its effort to produce sharply higher-resolution brain maps, thanks to technology from EMC Corporation.
Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.
By the Media Relations Office, McGill Newsroom
Spotlight on neurosciences
Neuroinformatics stands at the intersection of neuroscience and information science. One of the world leaders in this discipline is Prof. Pedro Valdes-Sosa, General Vice-Director for Research of the Cuban Neuroscience Center (CNEURO) which he co-founded in 1990.
Gift expands scholarship program at McGill with $3.5 million gift
$3.5 million gift from McGill alumnus and long-time university supporter, Victor Phillip Dahdaleh, will make a major contribution to the field of brain research at the University and provide expanded support to the Victor Dahdaleh-Clinton Foundation Scholarship program.
By Katherine Gombay, McGill Newsroom
Discovery opens door to development of new drugs to control weight gain and obesity
It’s rare for scientists to get what they describe as “clean” results without spending a lot of time repeating the same experiment over and over again. But when researchers saw the mice they were working with doubling their weight within a month or two, they knew they were on to something.
By Cynthia Lee, McGill Newsroom
Study of repeat drunk drivers, speeding offenders finds distinct behavioural profiles
Road crashes are the world’s leading cause of preventable death and injury in people under 35, accounting for around 5 million casualties every year. Repeat offenders make a disproportionate contribution to these statistics – and are known for their poor response to education and prevention efforts.
Discovery offers hope for more effective treatments of deadly glioblastomas
A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.
The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.
By Fergus Grieve, McGill Newsroom
Depression, metabolic factors combine to boost risk of developing diabetes, study finds
Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.
By Shawn Hayward, Montreal Neurological Institute
Discovery will inform further research into hearing disorders and brain training
Scientists at the Montreal Neurological Institute and Hospital at McGill University have made an important discovery about the human auditory system and how to study it, findings that could lead to better testing and diagnosis of hearing-related disorders.
By Cynthia Lee, McGill Newsroom
Family and community involvement key in empowering students to make healthier choices regarding their sleep
Elementary school-age children who improved their sleep habits also improved in their academic performance, according to a study by researchers at McGill University and the Douglas Mental Health University Institute in partnership with the Riverside School Board in Montreal.
